1 The B 1 receptor for kinins, stimulated by kinin metabolites without the C-terminal Arg residue (e.g., des-Arg 9 -bradykinin (BK) and Lys-des-Arg 9 -BK), is an increasingly recognized molecular target for the development of analgesic and anti-in¯ammatory drugs. Recently developed antagonists of this receptor were compared to a conventional antagonist, Ac-Lys-[Leu 8 ]-des-Arg 9 -BK, in pharmacological assays based on the rabbit B 1 receptor.